Mike Raab

Directeur Général chez ARDELYX, INC. Fortune : 6 M $ au 31/08/2026

Profil

Michael G.
Raab is President, Chief Executive Officer & Director at Ardelyx, Inc. since 2009.
He is Chairman at TempestTx, Inc. since 2018.
He serves as Director at California Biomedical Innovation Alliance and at Tempest Therapeutics, Inc. since 2021.
He is a Member of the Governors Board at Biotechnology Innovation Organization since 2006.
Formerly, Mr. Raab was Executive Chairman at Amicus Therapeutics, Inc. from 2024 to 2026.
He was Director at Novalar Pharmaceuticals, Inc., Liquidia Technologies, Inc., ZP Opco, Inc., Hyperion Therapeutics, Inc., Cellgate, Inc., Novacea, Inc. from 2002 to 2009, and Millendo Therapeutics, Inc. He held Principal roles at Bristol Myers Squibb Co. and Repligen Corp.
He was Partner at NEA Management Co. LLC and New Enterprise Associates LLC from 2002 to 2008.
He was Senior Vice President at Therapeutics, Inc. and Senior Vice President-Therapeutics at Genzyme Corp.
from 1999 to 2002.
Mr. Raab completed undergraduate education at DePauw University in 1987.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ARDELYX, INC. 0,66%	21/08/2026	1 645 156 ( 0,66% )	6 M $	31/08/2026

Postes actifs de Mike Raab

Sociétés	Poste	Début
ARDELYX, INC.	Directeur Général	01/03/2009
TEMPEST THERAPEUTICS, INC.	Directeur/Membre du Conseil	27/01/2026
TempestTx, Inc.	Président	-
Biotechnology Innovation Organization	Directeur/Membre du Conseil	01/01/2006
California Biomedical Innovation Alliance	Directeur/Membre du Conseil	-

Anciens postes connus de Mike Raab

Sociétés	Poste	Fin
AMICUS THERAPEUTICS, INC.	Président	27/04/2026
Cellgate, Inc.	Directeur/Membre du Conseil	22/06/2009
Novacea, Inc.	Directeur/Membre du Conseil	03/02/2009
New Enterprise Associates LLC	Corporate Officer/Principal	01/12/2008
░░░ ░░░░░░░░░░ ░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░